William Blair Has Pessimistic Outlook of Zoetis Q4 Earnings

Zoetis Inc. (NYSE:ZTS) – Stock analysts at William Blair dropped their Q4 2024 earnings estimates for Zoetis in a note issued to investors on Monday, November 4th. William Blair analyst B. Vazquez now expects that the company will post earnings of $1.37 per share for the quarter, down from their prior forecast of $1.44. The consensus estimate for Zoetis’ current full-year earnings is $5.91 per share. William Blair also issued estimates for Zoetis’ Q2 2025 earnings at $1.67 EPS, Q3 2025 earnings at $1.70 EPS, FY2025 earnings at $6.36 EPS and Q3 2026 earnings at $1.91 EPS.

Several other research firms also recently commented on ZTS. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. JPMorgan Chase & Co. raised their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Stifel Nicolaus boosted their target price on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. BTIG Research raised their price target on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Finally, Piper Sandler lifted their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Ten research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Zoetis currently has an average rating of “Buy” and a consensus price target of $221.44.

Zoetis Stock Up 2.3 %

Shares of NYSE ZTS opened at $174.34 on Thursday. The company has a debt-to-equity ratio of 1.32, a current ratio of 3.45 and a quick ratio of 2.09. The stock has a market capitalization of $78.98 billion, a PE ratio of 32.67, a P/E/G ratio of 2.68 and a beta of 0.90. Zoetis has a one year low of $144.80 and a one year high of $201.92. The business’s fifty day moving average price is $188.46 and its 200-day moving average price is $179.17.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 52.59% and a net margin of 26.55%. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. During the same quarter in the prior year, the business earned $1.36 earnings per share. Zoetis’s revenue for the quarter was up 11.6% on a year-over-year basis.

Institutional Trading of Zoetis

Large investors have recently modified their holdings of the business. Geneos Wealth Management Inc. lifted its position in Zoetis by 15.4% during the first quarter. Geneos Wealth Management Inc. now owns 5,247 shares of the company’s stock valued at $888,000 after purchasing an additional 699 shares during the last quarter. Advisory Alpha LLC grew its position in Zoetis by 28.7% in the first quarter. Advisory Alpha LLC now owns 2,199 shares of the company’s stock worth $372,000 after acquiring an additional 490 shares in the last quarter. Manchester Capital Management LLC increased its stake in Zoetis by 12.8% in the first quarter. Manchester Capital Management LLC now owns 2,246 shares of the company’s stock valued at $380,000 after acquiring an additional 255 shares during the last quarter. Duality Advisers LP raised its position in Zoetis by 43.7% during the first quarter. Duality Advisers LP now owns 40,641 shares of the company’s stock valued at $6,877,000 after purchasing an additional 12,359 shares in the last quarter. Finally, Empirical Finance LLC lifted its stake in Zoetis by 3.4% during the first quarter. Empirical Finance LLC now owns 16,757 shares of the company’s stock worth $2,835,000 after purchasing an additional 554 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be paid a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a yield of 0.99%. Zoetis’s dividend payout ratio is currently 32.33%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.